Acerus Announces Acceptance of Two NATESTO® Clinical Studies for Presentation at the American Urological Association Annual Scientific Program
BioSpace,
Feb. 5, 2020 13:30 UTC TORONTO--( BUSINESS WIRE )-- Acerus Pharma Corporation (“Acerus” or the “Company”) (TSX:ASP, OTCQB:ASPCF…